Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
NCT07228052 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 182
Last updated 2026-03-09
Summary
This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health System.
Conditions
Interventions
- DRUG
-
Dexamethasone 16mg IM
Dexamethasone 16mg Intramuscular Administration Once
- DRUG
-
Prednisone 60mg PO
Prednisone 60mg PO for 5 Days
Sponsors & Collaborators
-
Montefiore Medical Center
lead OTHER
Principal Investigators
-
Carlo Lutz, MD · Montefiore Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children
NCT03698630 ·Status: COMPLETED ·Phase: PHASE4
-
Steroids in Children Hospitalized With Asthma
NCT02780479 ·Status: TERMINATED ·Phase: PHASE4
-
Early Administration of Steroids in the Ambulance Setting
NCT03962894 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
NCT00588406 ·Status: COMPLETED ·Phase: PHASE3
-
Steroids In The Management Of Acute Asthma Exacerbations In Children, Which Form Is More Suitable?
NCT03204760 ·Status: UNKNOWN ·Phase: PHASE2
-
Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma
NCT01065272 ·Status: COMPLETED ·Phase: PHASE1
-
Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
NCT04016220 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma
NCT00685022 ·Status: COMPLETED ·Phase: PHASE2
-
Dexamethasone Versus Prednisone for Asthma Treatment in the Pediatric Inpatient Population; a Feasibility Study
NCT03133897 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
NCT00683449 ·Status: TERMINATED ·Phase: PHASE2
-
Dexamethasone Tolerability in the Treatment of Acute Asthma in Children
NCT00973687 ·Status: COMPLETED ·Phase: NA
-
Repeat Emergency Department Visits Among Patients With Asthma and COPD
NCT02499887 ·Status: TERMINATED ·Phase: NA
-
Asthma Patient Education in the Emergency Room
NCT00110409 ·Status: COMPLETED ·Phase: NA
-
Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients
NCT00627731 ·Status: COMPLETED ·Phase: PHASE4
-
ASTHMAXcel Emergency Department Study
NCT05013073 ·Status: TERMINATED ·Phase: NA
-
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
NCT00585039 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
NCT05763121 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
NCT05748600 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Symptom Clusters in Children With Exacerbation-prone Asthma
NCT04002362 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pulmozyme to Treat Severe Asthma Episodes
NCT00169962 ·Status: COMPLETED ·Phase: PHASE2
-
(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
NCT00394329 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
NCT00073827 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.
NCT01025648 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma
NCT00048022 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
NCT00819637 ·Status: TERMINATED ·Phase: PHASE4